Early Antibiotic Use after Fecal Microbiota Transplantation Increases Risk of Treatment Failure

Clinical Infectious Diseases

Volumn 66, Issue 1, 2018, Pages 134-135

  Allegretti, Jessica R ^a   Kao, Dina ^b   Sitko, Jessica ^a   Fischer, Monika ^c   Kassam, Zain ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c INDIANA UNIVERSITY   (United States)

^d Open Biome   (United States)

Author keywords

Antibiotics; Clostridium difficile; Diarrhea; Fecal transplant

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CIPROFLOXACIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ANTIMICROBIAL STEWARDSHIP; ARTICLE; CELLULITIS; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DISEASE SEVERITY; DRUG USE; ENZYME IMMUNOASSAY; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT INFECTION; RETROSPECTIVE STUDY; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT FAILURE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; AGED; RISK ASSESSMENT; TIME FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT FAILURE;

EID: 85040633628     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix684     Document Type: Article

References (5)

1. Cammarota G, Ianiro G, Tilg H, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 2017; 66:569-80.
2. Crobach MJ, Planche T, Eckert C, et al. European Society of Clinical Microbiology and Infectious Diseases: Update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 2016; 22(suppl 4):S63-81.
3. Wilcox MH, Gerding DN, Poxton IR, et al; MODIFY I and MODIFY II Investigators. Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N Engl J Med 2017; 376:305-17.
4. Fischer M, Kao D, Mehta SR, et al. Predictors of early failure after fecal microbiota transplantation for the therapy of Clostridium Difficile infection: A multicenter study. Am J Gastroenterol 2016; 111:1024-31.
5. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107:761-7.